Adjuvant Induces T Cells, but Keeps Them for Itself

Cancer immunotherapy has high hopes riding on it these days. In contrast to the spectacular but extremely short-lived effects of targeted therapies, where immunotherapy works, it often leads to remissions that last for years. But it doesn't work often.